US 10981951
Therapeutics for the treatment of glaucoma
granted A61KA61K31/353A61K31/4025
Quick answer
US patent 10981951 (Therapeutics for the treatment of glaucoma) held by Regents of the University of Minnesota expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Regents of the University of Minnesota
- Grant date
- Tue Apr 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/353, A61K31/4025, A61K31/4439, A61K31/454